CompletedNCT06530758
Does the Format of the Adult ADHD Self-Report Scale Impact the Results
This study is completed. It focuses on ADHD and currently lists study information in Canada.
In EdmontonADHDOtherFrom 19 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT06496685
Dog Assisted Therapy Program for Children With ADHD
This study is completed. It focuses on ADHD and currently lists study information in Spain.
In LleidaADHDOtherFrom 7 Years to 12 Years
WithdrawnNCT05060549
Dopamine D3 Receptor Occupancy in Depression in bipolarity
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In New YorkBipolarity, DepressionOtherFrom 18 Years to 60 Years
CompletedNCT02560389
Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
This study is completed. It focuses on PTSD and currently lists study information in the United States.
In Little RockPTSDDrugA study involving a medication or substance.From 25 Years to 50 Years
CompletedNCT00116077
Dopamine Receptor Imaging in Mood Disorders
This study is completed. It focuses on depression and currently lists study information in the United States.
In BethesdaDepression, BipolarityOtherFrom 18 Years to 55 Years
CompletedNCT02225106
Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In BethesdaADHDOtherFrom 18 Years to 55 Years
CompletedNCT04469959
Dopaminergic Dysfunction in Late-Life Depression
This study is completed. It focuses on depression and currently lists study information in the United States.
Multiple locations, including PittsburghDepressionOtherOver 60 Years
OngoingEUCTR 2013-001315-71
Dopaminergic genotype of schizophrenic patients and the benefit of adjunctive aripiprazole to risperidone treatment. The effect on hormonal and metabolic measures
This study is ongoing in Spain. It focuses on Schizophrenia.
In SpainSchizophreniaOther
CompletedNCT00610441
Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)
This study is completed. It focuses on ADHD and currently lists study information in Global.
In GlobalADHDOtherFrom 18 Years to 50 Years
CompletedNCT02255565
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Study
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In SeattleADHDOtherFrom 5 Years to 16 Years
CompletedNCT02066792
Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
This study is completed. It focuses on anxiety and currently lists study information in the United States.
Multiple locations, including ChicagoAnxietyOtherFrom 18 Years to 70 Years
CompletedNCT01081132
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
This study is completed. It focuses on ADHD and currently lists study information in the United States.
Multiple locations, including DothanADHDOtherFrom 13 Years to 17 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.